Hans-Michael Kvasnicka

7PUBLICATIONS
48CO-AUTHORS
Cancer geneticsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)NeonatologyImmunogenetics (incl. genetic immunology)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Aug 13, 2026
HPV Genotype Landscape in Anal Squamous Cell Carcinoma Across Primary, Recurrent, and Metastatic Tumor Specimens.

|Dec 29, 2022
International Consensus Classification of myeloid and lymphoid neoplasms: myeloproliferative neoplasms.

Umberto Gianelli, Jürgen Thiele, Attilio Orazi

|Jul 12, 2022
EAHP 2020 workshop proceedings, pediatric myeloid neoplasms.

R J Leguit, A Orazi, N Kucine

|Jun 29, 2022
International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data.

Daniel A Arber, Attilio Orazi, Robert P Hasserjian

|Jul 21, 2020
Proteome activity landscapes of tumor cell lines determine drug responses.

Martin Frejno, Chen Meng, Benjamin Ruprecht

|Mar 17, 2018
Long-term effects of ruxolitinib versus best available therapy on bone marrow fibrosis in patients with myelofibrosis.

Hans Michael Kvasnicka, Jürgen Thiele, Carlos E Bueso-Ramos

Pageof 2

Frequent Collaborators

2 joint publications

Umberto Gianelli

2 joint publications

Daniel A Arber

2 joint publications

Alessandro M Vannucchi

2 joint publications

Tiziano Barbui